4.7 Article

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

期刊

TRANSLATIONAL PSYCHIATRY
卷 12, 期 1, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41398-022-01941-x

关键词

-

资金

  1. Intramural Research Program of the NIH, National Institute on Aging [IRP-NIA-NIH-ZIA000297-08]
  2. National Institute of Mental Health (IRP-NIMH-NIH) [ZIAMH002927, NCT03065335]
  3. National Center for Advancing Translational Sciences
  4. VA Merit Awards [1I01BX004062, 101BX003631-01A1]
  5. NIH [R01MH107615, R21AI145211-01A1]

向作者/读者索取更多资源

Subanesthetic-dose ketamine has rapid and sustained antidepressant effects, and its metabolite (2 R,6 R)-HNK also exhibits similar effects. Metabolomic analysis reveals the involvement of inflammatory pathways in the effects of ketamine and (2 R,6 R)-HNK, with potential differences between mice and humans.
Subanesthetic-dose racemic (R,S)-ketamine (ketamine) produces rapid, robust, and sustained antidepressant effects in major depressive disorder (MDD) and bipolar disorder (BD) and has also been shown to effectively treat neuropathic pain, complex regional pain syndrome, and post-traumatic stress disorder (PTSD). However, to date, its mechanism of action remains unclear. Preclinical studies found that (2 R,6 R;2 S,6 S)-hydroxynorketamine (HNK), a major circulating metabolite of ketamine, elicits antidepressant effects similar to those of ketamine. To help determine how (2 R,6 R)-HNK contributes to ketamine's mechanism of action, an exploratory, targeted, metabolomic analysis was carried out on plasma and CSF of nine healthy volunteers receiving a 40-minute ketamine infusion (0.5 mg/kg). A parallel targeted metabolomic analysis in plasma, hippocampus, and hypothalamus was carried out in mice receiving either 10 mg/kg of ketamine, 10 mg/kg of (2 R,6 R)-HNK, or saline. Ketamine and (2 R,6 R)-HNK both affected multiple pathways associated with inflammatory conditions. In addition, several changes were unique to either the healthy human volunteers and/or the mouse arm of the study, indicating that different pathways may be differentially involved in ketamine's effects in mice and humans. Mechanisms of action found to consistently underlie the effects of ketamine and/or (2 R,6 R)-HNK across both the human metabolome in plasma and CSF and the mouse arm of the study included LAT1, IDO1, NAD(+), the nitric oxide (NO) signaling pathway, and sphingolipid rheostat.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据